Analysis of medication safety matters that need to be paid attention to while taking apalutamide (Ansenko)

Apalutamide (Apalutamide) is a non-steroidal androgen receptor inhibitor, mainly used to treat non-metastatic castration-resistant prostate cancer (nmCRPC) and some patients with metastatic prostate cancer. It inhibits tumor cell proliferation and metastasis by blocking the binding of androgens to receptors. Although the efficacy is significant, side effects or drug interactions may occur during medication, so medication safety needs to be paid attention to to ensure efficacy and tolerability.

Common side effects of apalutamide include fatigue, rash, thyroid dysfunction, increased blood pressure, and increased risk of fractures. Patients should pay attention to regular monitoring of blood pressure, thyroid function and bone density while taking the medication. If you have a mild rash, you can use anti-allergic drugs or local skin care measures. If you have a severe rash, you need to contact your doctor in time. To reduce the risk of fractures, calcium and vitamin DD should be supplemented, combined with moderate exercise, and bone protection drugs should be used under the guidance of a doctor.

The metabolism of apalutamide mainly relies on theCYP2C8 and CYP3A4 enzyme systems, so it is associated with strong potency The combined use of pan>CYP3A4 or CYP2C8 inhibitors and inducers may affect the blood concentration of the drug, resulting in reduced efficacy or increased toxicity. Patients should inform their doctors of all prescription drugs, over-the-counter drugs and health care products they are taking while taking the medication, and avoid discontinuing the medication on their own or using drugs that may interact with each other.

To ensure medication safety, apalutamide should be taken orally at a fixed time every day, on an empty stomach or with food. Do not adjust the dosage yourself. Patients should regularly review hematology, liver function and electrocardiogram, and promptly report any abnormal symptoms, such as persistent fatigue, edema or dyspnea. Through scientific management, regular monitoring and doctor-patient communication, the therapeutic effect of apalutamide can be maximized while reducing the risk of side effects and achieving long-term safe medication.

Reference materials:https://www.drugs.com/

xa0